Poniard Pharmaceuticals, Inc. (PARD) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-10.88M
Depreciation and amortization	951K
Amortization of discount on note payable	0
Gain realized on sale of investment securities	-8K
Accretion of premium on investment securities	14K
Loss on disposal of facilities and equipment	0
Restructuring	0
Interest accrued on capital lease obligation	66K
Share-based compensation issued for services	-12K
Share-based employee compensation	2.52M
Prepaid expenses and other assets	483K
Accounts payable	1.09M
Accrued liabilities	224K
Net cash used in operating activities	-5.41M
Proceeds from maturities of investment securities	3.03M
Purchases of investment securities	0
Facilities and equipment purchases	-9K
Proceeds from disposals of equipment and facilities	0
Net cash provided by investing activities	3.02M
Repayment of principal on note payable	0
Repayment of capital lease obligation	0
Decrease in restricted cash	0
Net proceeds from issuance of common stock	3.18M
Payment of preferred dividends	-96K
Net cash provided by financing activities	3.09M
Net increase (decrease) in cash and cash equivalents	700K
Beginning of period	1.28M
End of period	1.98M
Accrual of preferred dividends	144K
Preferred stock dividends, in-kind	0
Interest	0

Entities mentioned with PARD

View All Entities